To minimize time, costs, and boost the success rates of new pharmaceuticals to market, the pharmaceutical industry is turning to AI-based methodologies. One of the most common reasons for FDA approval failures and recalls is drug safety. In drug development and safety, AI and deep learning techniques have shown a lot of potential when compared to traditional techniques. The rush to use AI is on, with over a hundred new businesses following this line of inquiry.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
